Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Jun 13;69(23):2821-2830.
doi: 10.1016/j.jacc.2017.04.026.

Marfan Syndrome and Quality of Life in the GenTAC Registry

Judith Z Goldfinger  1 , Liliana R Preiss  2 , Richard B Devereux  3 , Mary J Roman  3 , Tabitha P Hendershot  2 , Barbara L Kroner  2 , Kim A Eagle  4 ; GenTAC Registry Consortium
Affiliations
Observational Study

Marfan Syndrome and Quality of Life in the GenTAC Registry

Judith Z Goldfinger et al. J Am Coll Cardiol. .

Abstract

Background: Previous small studies suggested reduced quality of life (QOL) for people with Marfan syndrome (MFS) compared with those without MFS. The national registry of GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) is a longitudinal observational cohort study of patients with conditions that predispose to thoracic aortic aneurysms and dissections, including MFS. At the time of registry enrollment, GenTAC study participants are asked to complete questionnaires about demographics, medical history, health habits, and QOL.

Objectives: This study assessed QOL in GenTAC participants with MFS and identify associated factors using self-reported data.

Methods: QOL was assessed using the 4 subscales of the Physical Component Summary (PCS) of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36): physical functioning; role limitations due to physical health; bodily pain; and general health. We studied the association of QOL with self-reported demographics, health behaviors, physical impairments, surgeries, comorbid medical conditions, medications, and MFS severity.

Results: In the GenTAC registry, 389 adults with MFS completed the SF-36. Mean age was 41 years, 51% were men, 92% were white, and 65% were college graduates. The mean PCS composite score was 42.3. In bivariate analysis, predictors of better QOL included college education, marital status, higher household income, private health insurance, full-time employment, moderate alcohol use, fewer prior surgeries, fewer comorbid conditions, absence of depression, and less severe MFS manifestations. In a multivariable analysis, insurance status and employment remained significant predictors of QOL.

Conclusions: In a large cohort of patients with MFS in the GenTAC registry, health-related QOL was below the population norm. Better QOL was independently associated with socioeconomic factors, not factors related to general health or MFS severity.

Keywords: GenTAC; Marfan syndrome; SF-36; quality of life.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Central Illustration. Factors that Impact Quality of Life in Marfan Syndrome
See this image and copyright information in PMC

Comment in

References

    1. Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75:157–60. - PubMed
    1. Song HK, Bavaria JE, Kindem MW, et al. Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann Thorac Surg. 2009;88:781, 7. discussion 787–8. - PMC - PubMed
    1. Holmes KW, Maslen CL, Kindem M, et al. GenTAC registry report: Gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection. Am J Med Genet A. 2013;161A:779–86. - PMC - PubMed
    1. Weinsaft JW, Devereux RB, Preiss LR, et al. Aortic dissection in patients with genetically mediated aneurysms: incidence and predictors in the GenTAC registry. J Am Coll Cardiol. 2016;67:2744–54. - PMC - PubMed
    1. Verbraecken J, Declerck A, Van de Heyning P, De Backer W, Wouters EF. Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: A questionnaire study. Clin Genet. 2001;60:360–5. - PubMed

Publication types